L A Murakata

Summary

Affiliation: Armed Forces Institute of Pathology
Country: USA

Publications

  1. ncbi Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma
    L A Murakata
    Armed Forces Institute of Pathology, Department of Hepatic and Gastrointestinal Pathology, Washington, DC 20306 6000, USA
    Mod Pathol 13:874-81. 2000
  2. ncbi Expression of inhibin-alpha by granular cell tumors of the gallbladder and extrahepatic bile ducts
    L A Murakata
    Department of Hepatic and GI Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Am J Surg Pathol 25:1200-3. 2001
  3. ncbi Characterization of acrylic polyamide plastic embolization particles in vitro and in human tissue sections by light microscopy, infrared microspectroscopy and scanning electron microscopy with energy dispersive X-ray analysis
    Linda A Murakata
    Armed Forces Institute of Pathology AFIP, Washington, DC 20306 6000, USA
    Mod Pathol 19:922-30. 2006
  4. ncbi Gallbladder carcinoma: radiologic-pathologic correlation
    A D Levy
    Department of Radiologic Pathology, Armed Forces Institute of Pathology, 6825 16th St NW, Bldg 54, Rm M 121, Washington, DC 20306 6000, USA
    Radiographics 21:295-314; questionnaire, 549-55. 2001
  5. ncbi Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma
    Robert L Zimmerman
    Department of Pathology W 547, Presbyterian Medical Center, University of Pennsylvania Health Sysytem, Philadelphia, PA 19104, USA
    Oncol Rep 9:689-92. 2002
  6. ncbi The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma
    Robert L Zimmerman
    Department of Pathology W 547, Presbyterian Medical Center, Philadelphia, PA 19104, USA
    Oncol Rep 9:1369-72. 2002

Collaborators

  • A D Levy
  • Robert L Zimmerman
  • Melissa Burke
  • Franz Fogt
  • Kiron M Das

Detail Information

Publications6

  1. ncbi Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma
    L A Murakata
    Armed Forces Institute of Pathology, Department of Hepatic and Gastrointestinal Pathology, Washington, DC 20306 6000, USA
    Mod Pathol 13:874-81. 2000
    ....
  2. ncbi Expression of inhibin-alpha by granular cell tumors of the gallbladder and extrahepatic bile ducts
    L A Murakata
    Department of Hepatic and GI Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Am J Surg Pathol 25:1200-3. 2001
    ..This study adds the granular cell tumor to the list of inhibin-positive lesions and should prove helpful in differential diagnosis of these lesions...
  3. ncbi Characterization of acrylic polyamide plastic embolization particles in vitro and in human tissue sections by light microscopy, infrared microspectroscopy and scanning electron microscopy with energy dispersive X-ray analysis
    Linda A Murakata
    Armed Forces Institute of Pathology AFIP, Washington, DC 20306 6000, USA
    Mod Pathol 19:922-30. 2006
    ..In cases lacking appropriate clinical information, identification by these methods and/or a panel of special stains may assist pathologists unfamiliar with this material's light microscopic appearance...
  4. ncbi Gallbladder carcinoma: radiologic-pathologic correlation
    A D Levy
    Department of Radiologic Pathology, Armed Forces Institute of Pathology, 6825 16th St NW, Bldg 54, Rm M 121, Washington, DC 20306 6000, USA
    Radiographics 21:295-314; questionnaire, 549-55. 2001
    ..The radiologic differential diagnosis includes the more frequently encountered inflammatory conditions of the gallbladder, xanthogranulomatous cholecystitis, adenomyomatosis, other hepatobiliary malignancies, and metastatic disease...
  5. ncbi Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma
    Robert L Zimmerman
    Department of Pathology W 547, Presbyterian Medical Center, University of Pennsylvania Health Sysytem, Philadelphia, PA 19104, USA
    Oncol Rep 9:689-92. 2002
    ..Glut-1 is a highly specific but insensitive stain for Chca. It may prove to be a helpful part of a diagnostic panel used to evaluate liver lesions...
  6. ncbi The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma
    Robert L Zimmerman
    Department of Pathology W 547, Presbyterian Medical Center, Philadelphia, PA 19104, USA
    Oncol Rep 9:1369-72. 2002
    ..The Das-1 immunostain may play a useful role in evaluating liver malignancies...